Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

151.18 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,138
Open 151.18
Bid (Size) 151.24 (1)
Ask (Size) 151.52 (1)
Prev. Close 151.18
Today's Range 151.18 - 151.18
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
Investors should look for opportunities to buy these leading healthcare companies, each of which posted strong Q1 results. 
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical,
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
-5.49%
-5.49%
1 Month
-4.18%
-4.18%
3 Month
-4.86%
-4.86%
6 Month
+1.67%
+1.67%
1 Year
-8.39%
-8.39%

More News

Read More
Johnson & Johnson Wants To Deal With Talc Lawsuit Overhang, Proposes $6.5B Settlement Package
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Dow Jones Industrial Average Struggles To Recover From Recent Backslide As Fed Rounds Corner
Via Talk Markets
Topics Economy Stocks
Exposures Interest Rates US Equities
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
Via Benzinga
Johnson & Johnson Stock: Buy, Sell, or Hold?
Via The Motley Fool
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Why Is CytomX (CTMX) Stock Up 180% Today?
Via InvestorPlace
JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits
Via InvestorPlace
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
From Johnson & Johnson
Via Business Wire
3 No-Brainer Stocks to Buy With $200 Right Now
Via The Motley Fool
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Healthcare Stocks
Via InvestorPlace
3 Stocks Mega Investors Are Buying
Via MarketBeat
Topics Regulatory Compliance
Exposures Legal Regulatory
Slump Survivors: 3 Stocks That Will Outlast the S&P 500 Downturn
Via InvestorPlace
Topics Stocks
Exposures US Equities
Cutting Edge Picks: 3 Med Tech Stocks With Room to Run
Via InvestorPlace
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
Via Benzinga
Johnson & Johnson Is a King of Dividend Safety
Via The Motley Fool
7 Retirement Stocks to Buy at a 52-Week Low in April
Via InvestorPlace
Topics Retirement
Exposures Pension
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
Via Talk Markets
2 Top Growth Stocks to Buy Right Now and Hold Forever
Via The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
Via The Motley Fool
5 Stocks In Focus On Their Recent Dividend Hikes
Via Talk Markets
7 Stocks to Buy if Inflation Continues to Reign in 2024
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Generational Wealth Builders: 3 Stocks to Own for Decades of Gains
Via InvestorPlace
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.